Treatment of Patients with Myelodysplastic Syndromes with Recombinant Human Granulocyte/Macrophage Colony-Stimulating Factor: A Phase I/II Trial

[1]  T. Fliedner,et al.  Chronic myelocytic leukaemia: cytogenetical studies on haemopoietic colonies and diffusion chamber cultures. , 2009, Scandinavian journal of haematology.

[2]  R. Bast,et al.  Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation. , 1988, The New England journal of medicine.

[3]  C. Begley,et al.  Proliferation of normal human promyelocytes and myelocytes after a single pulse stimulation by purified GM-CSF or G-CSF. , 1988, Blood.

[4]  J. Gutterman,et al.  Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes. , 1987, The New England journal of medicine.

[5]  G. Tricot,et al.  Management of the myelodysplastic syndromes. , 1987, Seminars in oncology.

[6]  J. Groopman,et al.  Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in the acquired immunodeficiency syndrome. , 1987, The New England journal of medicine.

[7]  J. Adamson,et al.  Clonal development, stem-cell differentiation, and clinical remissions in acute nonlymphocytic leukemia. , 1987, The New England journal of medicine.

[8]  P. Morrissey,et al.  Granulocyte-macrophage colony-stimulating factor augments the primary antibody response by enhancing the function of antigen-presenting cells. , 1987, Journal of immunology.

[9]  R. Gale,et al.  Low dose cytosine arabinoside in myelodysplasia and acute myelogenous leukemia: a review. , 1987, Leukemia.

[10]  E. Vellenga,et al.  Effects of recombinant IL-3, GM-CSF, and G-CSF on proliferation of leukemic clonogenic cells in short-term and long-term cultures. , 1987, Leukemia.

[11]  T. Kupper,et al.  Growth of an interleukin 2/interleukin 4-dependent T cell line induced by granulocyte-macrophage colony-stimulating factor (GM-CSF). , 1987, Journal of immunology.

[12]  A. Woods,et al.  Granulocyte-macrophage colony stimulating factor produced by cloned L3T4a+, class II-restricted T cells induces HT-2 cells to proliferate. , 1987, Journal of immunology.

[13]  R. Kamen,et al.  The human hematopoietic colony-stimulating factors. , 1987, Science.

[14]  E. Vellenga,et al.  Acute Myeloblastic Leukemia , 1996 .

[15]  J. Gabrilove,et al.  Activities of four purified growth factors on highly enriched human hematopoietic progenitor cells. , 1987, Blood.

[16]  J. Kere,et al.  Monosomy 7 in granulocytes and monocytes in myelodysplastic syndrome. , 1987, The New England journal of medicine.

[17]  R. Hoffman,et al.  A trial of recombinant α2 interferon in the myelodysplastic syndromes: I. Clinical results , 1987 .

[18]  B. Savage,et al.  A trial of recombinant alpha 2 interferon in the myelodysplastic syndrome: II. Characterization and response of granulocyte and platelet dysfunction. , 1987, Leukemia.

[19]  C. Begley,et al.  Purified colony stimulating factors (G‐CSF and GM‐CSF) induce differentiation in human HL60 leukemic cells with suppression of clonogenicity , 1987, International journal of cancer.

[20]  R. Simon,et al.  A critical appraisal of low-dose cytosine arabinoside in patients with acute non-lymphocytic leukemia and myelodysplastic syndromes. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  Greenberg Pl.  In vitro culture techniques defining biological abnormalities in the myelodysplastic syndromes and myeloproliferative disorders. , 1986 .

[22]  Galton Da,et al.  Myelodysplastic syndromes: natural history and features of prognostic importance. , 1986, Clinics in haematology.

[23]  J. Griffin,et al.  The role of colony stimulating factors in leukaemogenesis. , 1986, Clinics in haematology.

[24]  B. Vogelstein,et al.  Differentiation of leukemia cells to polymorphonuclear leukocytes in patients with acute nonlymphocytic leukemia. , 1986, The New England journal of medicine.

[25]  D. Friend,et al.  Characterization of the cell surface receptor for human granulocyte/macrophage colony-stimulating factor , 1986, The Journal of experimental medicine.

[26]  F. Hecht,et al.  13-cis retinoic acid treatment for myelodysplastic syndromes. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  R. Donahue,et al.  Human recombinant granulocyte-macrophage colony-stimulating factor: a multilineage hematopoietin. , 1985, Science.

[28]  T. C. Barnett,et al.  Phase I-II study of 13-cis-retinoic acid in myelodysplastic syndrome. , 1985, Cancer treatment reports.

[29]  H. Koeffler,et al.  1,25-Dihydroxyvitamin D3: in vivo and in vitro effects on human preleukemic and leukemic cells. , 1985, Cancer treatment reports.

[30]  D. Cerretti,et al.  Cloning, sequence, and expression of a human granulocyte/macrophage colony-stimulating factor. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[31]  J. Armitage,et al.  Myelodysplastic syndromes. A clinical and pathologic analysis of 109 cases , 1985, Cancer.

[32]  R. Larson.  Management of myelodysplastic syndromes. , 1985, Annals of internal medicine.

[33]  A. Ganser,et al.  Megakaryocytic cells in mixed haemopoietic colonies (CFU‐GEMM) from the peripheral blood of normal individuals , 1985, British journal of haematology.

[34]  D. Machin,et al.  Myelodysplastic syndromes: a scoring system with prognostic significance , 1985, British journal of haematology.

[35]  F. Brown,et al.  Ages of tuff beds at East African early hominid sites and sediments in the Gulf of Aden , 1985, Nature.

[36]  D. Golde,et al.  Purified human granulocyte-macrophage colony-stimulating factor: direct action on neutrophils. , 1984, Science.

[37]  G. Tricot,et al.  Bone marrow histology in myelodysplastic syndromes , 1984, British journal of haematology.

[38]  G. Tricot,et al.  Bone marrow histology in myelodysplastic syndromes , 1984, British journal of haematology.

[39]  J. Desforges.  Cytarabine: low-dose, high-dose, no dose? , 1983, The New England journal of medicine.

[40]  M. Oken,et al.  Chronic myelodysplastic syndrome: short survival with or without evolution to acute leukaemia , 1983, British journal of haematology.

[41]  H. Gralnick,et al.  Proposals for the classification of the myelodysplastic syndromes , 1982, British journal of haematology.

[42]  D. Metcalf.  Clonal analysis of the action of GM‐CSF on the proliferation and differentiation of myelomonocytic leukemic cells , 1979, International journal of cancer.

[43]  H. Kantarjian,et al.  Hematologic response of four patients with smoldering acute myelogenous leukemia to partially pure gamma interferon. , 1987, Leukemia.

[44]  P. Hokland,et al.  13-cis retinoic acid treatment of myelodysplastic syndromes. , 1987, Leukemia research.

[45]  C. Begley,et al.  Primary human myeloid leukemia cells: comparative responsiveness to proliferative stimulation by GM-CSF or G-CSF and membrane expression of CSF receptors. , 1987, Leukemia.

[46]  I. Bernstein,et al.  Leukocyte Typing II , 1986, Springer New York.

[47]  Clark,et al.  Biologic properties in vitro of a recombinant human granulocyte-macrophage colony-stimulating factor. , 1986, Blood.

[48]  E. Reinherz.  Human T lymphocytes , 1986 .

[49]  P. Sehgal,et al.  Stimulation of haematopoiesis in primates by continuous infusion of recombinant human GM-CSF , 1986, Nature.

[50]  M. Tomonaga,et al.  Biosynthetic (recombinant) human granulocyte-macrophage colony-stimulating factor: effect on normal bone marrow and leukemia cell lines. , 1986, Blood.

[51]  E. Fritsch,et al.  Isolation and characterization of genomic and cDNA clones of human erythropoietin , 1985, Nature.

[52]  H. Heimpel,et al.  "Atypical" leukemias: preleukemia, smoldering leukemia and hypoplastic leukemia. , 1984, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[53]  H. Messner,et al.  The growth of large megakaryocyte colonies from human bone marrow , 1982, Journal of cellular physiology. Supplement.

[54]  A. Miller,et al.  Reporting results of cancer treatment , 1981, Cancer.